Perspective Therapeutics, Inc announced that it has entered into an investment agreement in a private placement to issue 92,009,981 shares of its common stock at a price of $0.95 per share for a gross proceeds $87,409,481.95 on March 4, 2024. The private placement is expected to close on March 6, 2024, subject to the satisfaction of customary closing conditions. The transaction included participation from new investor Lantheus Holdings, Inc. for $57.4 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.56 USD | +0.55% | +2.74% | +5.74% |
Apr. 18 | B. Riley Raises Price Target on Lantheus Holdings to $99 From $95, Keeps Buy Rating | MT |
Mar. 07 | Lantheus Holdings Insider Sold Shares Worth $262,005, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.74% | 4.49B | |
+0.89% | 12.8B | |
-10.29% | 7.61B | |
+1.78% | 5.41B | |
-1.16% | 4.51B | |
-50.70% | 3.29B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-11.50% | 1.73B | |
-5.02% | 1.64B |
- Stock Market
- Equities
- LNTH Stock
- News Lantheus Holdings, Inc.
- Perspective Therapeutics, Inc. announced that it expects to receive $87.409482 million in funding from Lantheus Holdings, Inc. and other investors